Given its potential to impact health, physicians should not hesitate to refer families with a strong history of cancer for genetic counseling and testing.
From a surgical standpoint, the transition to neoadjuvant therapy among patients with resectable NSCLC is feasible and safe, according to a study published in Clinical Lung Cancer. Jonathan D. Spicer, MD, PhD, and colleagues...
The International Association for the Study of Lung Cancer (IASCL) grading system can precisely predict patient outcomes for patients with lung cancer, according to a study published in Lung Cancer. In a retrospective study of...
For patients with metastatic NSCLC receiving immunotherapy, outcomes are similar across racial and ethnic groups, but Eastern Cooperative Oncology Group (ECOG) performance status (PS) is associated with survival, according to a...